Management of Stage 4 Chronic Kidney Disease

Introduction to Stage 4 CKD Management

• The American Diabetes Association recommends referring patients to nephrology immediately when stage 4 CKD develops (eGFR <30 mL/min/1.73 m²), as consultation reduces costs, improves quality of care, and delays dialysis 1, 2

Immediate Nephrology Referral

• All patients with eGFR <30 mL/min/1.73 m² require nephrology referral to prepare for potential renal replacement therapy and manage complex complications, according to the American Journal of Kidney Diseases 1, 3
• The National Kidney Foundation suggests beginning structured education about dialysis and transplantation options now, as preparation takes months and progression rates are unpredictable 6

Blood Pressure Management

• The American Heart Association recommends targeting systolic blood pressure <120 mmHg when tolerated using standardized office measurement 4, 5
• The American College of Cardiology suggests starting an ACE inhibitor or ARB as first-line therapy for blood pressure control and proteinuria reduction, titrated to maximum tolerated dose 6, 4

Diabetes Management

• The American Diabetes Association recommends starting an SGLT2 inhibitor with proven kidney or cardiovascular benefit if the patient has type 2 diabetes, as eGFR 25 is above the initiation threshold of ≥20 mL/min/1.73 m² 6, 4
• The European Association for the Study of Diabetes suggests reducing metformin dose to 1000 mg daily or discontinue, as eGFR 25 is below the safe threshold of 30 mL/min/1.73 m² 6

Cardiovascular Risk Reduction

• The American College of Cardiology recommends starting a moderate-intensity statin for primary prevention or high-intensity statin if the patient has known atherosclerotic cardiovascular disease 6

Preparation for Renal Replacement Therapy

• The National Kidney Foundation suggests creating arteriovenous fistula in advance for patients likely to require hemodialysis, as maturation takes weeks to months 4

Medication Safety

• The American Society of Nephrology recommends avoiding nephrotoxic agents including NSAIDs, COX-2 inhibitors, and iodinated contrast media 4

Urgent Indications for Dialysis Initiation

• The American Society of Nephrology suggests referring urgently if the patient develops uremic symptoms, BUN >100 mg/dL, altered mental status, refractory volume overload, severe hyperkalemia, uremic pericarditis, or severe metabolic acidosis (pH <7.2) 4, 5